PBA
BCYC
Paradigm Biocapital Advisors’s Bicycle Therapeutics BCYC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,246,759
| Closed | -$80.8M | – | 38 |
|
|
2024
Q1 | $80.8M | Sell |
3,246,759
-460,242
| -12% | -$11.5M | 2.85% | 18 |
|
|
2023
Q4 | $67M | Buy |
3,707,001
+64,694
| +2% | +$1.17M | 3.14% | 14 |
|
|
2023
Q3 | $73.2M | Buy |
3,642,307
+1,656,877
| +83% | +$33.3M | 4.97% | 6 |
|
|
2023
Q2 | $50.7M | Buy |
1,985,430
+168,649
| +9% | +$4.3M | 3.92% | 12 |
|
|
2023
Q1 | $38.6M | Buy |
1,816,781
+583,501
| +47% | +$12.4M | 3.66% | 15 |
|
|
2022
Q4 | $36.5M | Buy |
1,233,280
+74,594
| +6% | +$2.21M | 4.29% | 13 |
|
|
2022
Q3 | $27M | Buy |
1,158,686
+110,170
| +11% | +$2.56M | 3.59% | 12 |
|
|
2022
Q2 | $17.6M | Buy |
+1,048,516
| New | +$17.6M | 3.51% | 11 |
|